The Day by day Hit is a recap of hashish enterprise information for August 18, 2022.
ON THE SITE
Ayr Wellness Raises Steerage Regardless of Headwinds
Ayr Wellness Inc. (OTCQX: AYRWF) hiked its outlook for the yr on Thursday regardless of posting outcomes that missed expectations — as gross sales slip and losses rise. The multi-state operator reported monetary outcomes for the primary quarter ending June 30, 2022. Learn extra right here.
Decibel Sees File Income, Preps for Exports to Israel
Decibel Hashish Firm Inc. (TSX-V: DB) (OTCQB: DBCCF) posted promising outcomes because it continues to seek out beneficial properties within the Canadian market and abroad. The Alberta-based firm delivered its monetary report card utilizing Canadian {dollars} within the interval ending June 30, 2022. Learn extra right here.
Medical Marijuana Gross sales Slip within the Second Quarter
Medical Marijuana Inc. (OTC: MJNA) reported $7.8 million in internet income within the second quarter of 2022. This fell from final yr’s income of $9.6 million for a similar time interval in 2021. The corporate additionally reported a internet lack of $11 million versus final yr’s internet revenue of $7 million. Learn extra right here.
JuicyFields Ponzi Scheme Highlights Many Factors of Failure
Just like the plot of an inconceivable fintech thriller, hashish e-investment conglomerate JuicyFields has imploded into an obvious Ponzi scheme of huge proportions, leaving tens of hundreds of on-line traders questioning who’s liable for the most important swindle in hashish. Learn extra right here.
Individuals Notion of Psychedelics is Shifting
The science of psychedelics continues to validate what clinicians have identified for years about the advantages in treating psychological well being. Over the past 30 years, the science of psychedelics has accelerated and continues to validate what clinicians have identified for years about the advantages of psychedelics in treating psychological well being and wellness. Learn extra right here.
IN OTHER NEWS
Excessive Tide Inc.
Excessive Tide Inc. (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a retail-focused hashish firm with bricks-and-mortar in addition to world e-commerce property, introduced at this time that it has entered right into a binding dedication letter with Join First Credit score Union Ltd. for a $19 million credit score facility with an preliminary 5-year time period, at connectFirst’s flooring rate of interest. Learn extra right here.
PuraVerde, Inc.
PuraVerde, Inc., a hashish firm and operator, at this time introduced the launch of its streamlined Regulation A, Tier 2 public providing for each un-accredited and accredited traders. Driving modern analysis and growth, PuraVerde is formulating merchandise for the way forward for industrial hashish. Learn extra right here.
TYSON 2.0, Verano Holdings Corp.
TYSON 2.0, legendary boxer, entrepreneur, and hashish advocate Mike Tyson’s hashish firm at this time introduced the launch of its Ric Aptitude Drip Hashish line in partnership with Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), a multi-state hashish firm. Learn extra right here.
Zen Leaf Dispensary
Staff on the Verano/Zen Leaf Dispensary within the neighborhood of Pilsen have voted by a margin of greater than 90% to hitch Teamsters Native 777. The vote in favor of unionization comes regardless of the truth that the corporate fired union supporters through the marketing campaign. Learn extra right here.
Small Pharma Inc.
Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF), a biotechnology firm targeted on short-acting psychedelic-assisted therapies for psychological well being situations, at this time introduced that the TSX Enterprise Trade has accepted the corporate’s software for its regular course issuer bid for as much as 5 million frequent shares within the capital of the corporate, representing 1.55% of the issued and excellent shares, over a 12-month interval. Learn extra right here.
Brilliant Minds Biosciences
Brilliant Minds Biosciences (Nasdaq: DRUG) (CSE: DRUG), a biotechnology firm targeted on growing novel medication for focused remedy of neuropsychiatric problems, epilepsy and ache, issued this information launch in response to a request by the Funding Business Regulatory Group of Canada (IIROC) to touch upon current buying and selling exercise of its inventory. Learn extra right here.
Publish Views:
320
Disclosure
The statements made regarding these merchandise haven’t been evaluated by the Meals and Drug Administration. The efficacy of these merchandise has not been confirmed by FDA-approved evaluation. These merchandises are often not meant to diagnose, take care of, treatment, or forestall any sickness. All information discovered proper right here won’t be meant as another choice to or totally different from information from well-being care practitioners. Please search the recommendation of your well-being care expert about potential interactions or totally different attainable points sooner than using any product. The Federal Meals, Drug and Magnificence Act requires this discovery.
